the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Indonesia sees dengue case surge in Q1

JAKARTA: Dengue fever cases in Indonesia in the first quarter of 2024 has increased almost three times compared to the same period last year, said the Ministry of Health on Sunday.

According to the ministry, the number of cases has reached 43,271 by the 12th week of 2024, among which 343 people died, reported Xinhua.

Masdalina Pane, head of the Professional Development Division of the Association of Indonesian Epidemiologists, said that the current trend of increasing dengue cases had occurred since November 2023 in several areas. “But it seems like we are not serious about controlling it, so the area is expanding and cases continue to increase,“ he said.

“The main indicator for controlling an outbreak is that cases do not increase and do not spread. If cases and deaths continue to increase, that means we have failed to carry out control with quite a few victims,“ he continued.

Minister of Health Budi Gunadi Sadikin on Thursday said that the country had facilitated requests for larvicides and insecticides for dengue prevention needs.

He also reminded the public to complete dengue prevention with methods of eradicating mosquito nests, at least by draining standing water. – Bernama, Xinhua

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings